Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04409743 · ClinicalTrials.gov registry record · NA
Brief Telehealth CBT-I Intervention in the Context of the COVID-19 Pandemic
A NA study, sponsored by Stanford University.
- Completed
- Registry status
- NA
- Development phase
- 49
- Enrollment target
NCT04409743: Completed NA study, sponsored by Stanford University.
NCT04409743 is a NA study that has completed, run by Stanford University. The registered enrollment target is 49 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04409743, a NA study, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- NA
- Development phase
- 49 participants
- Enrollment target
Study Summary
The purpose of this study is to investigate whether an empirically validated treatment for insomnia (CBT-I) administered early in the course of sleep disturbance can prevent insomnia disorder or lessen negative mental health outcomes in the wake of the COVID-19 crisis in adults.
Interventions
- BEHAVIORAL Remote Cognitive Behavioral Therapy for Insomnia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 49 participants |
| Start Date | 2020-06-07 |
| Est. Completion | 2022-04-19 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04409743
The ClinicalTrials.gov registry entry for NCT04409743 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 49 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Remote Cognitive Behavioral Therapy for Insomnia is the first listed.
NCT04409743 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04409743 about?
NCT04409743 is a clinical study titled "Brief Telehealth CBT-I Intervention in the Context of the COVID-19 Pandemic". The purpose of this study is to investigate whether an empirically validated treatment for insomnia (CBT-I) administered early in the course of sleep disturbance can prevent insomnia disorder or lessen negative mental health outcomes in the wake of the COVID-19 crisis in adults.
What is the current status of trial NCT04409743?
This trial is currently completed. It is a NA study. The enrollment target is 49 participants. The study started on 2020-06-07. Estimated completion is 2022-04-19.
What interventions are being tested in trial NCT04409743?
The interventions under investigation include: Remote Cognitive Behavioral Therapy for Insomnia (BEHAVIORAL).
Who is sponsoring clinical trial NCT04409743?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.